Literature DB >> 12439617

TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population.

José A Garrote1, Eduardo Arranz, Juan J Tellería, Jesús Castro, Carmen Calvo, Alfredo Blanco-Quirós.   

Abstract

TNFalpha and TNFbeta, or linfotoxin (LTalpha), are two molecules playing an important role in inflammation. Their genes map on Chromosome 6, between the HLA class II and class I loci. Polymorphisms in, or near, TNF genes have been associated with susceptibility to several autoimmune diseases. Studies of TNF genes in celiac disease (CD) have presented contradictory results. We have assessed the role of TNFalpha and linfotoxin alpha (TNFbeta) in CD and their relative value as CD markers in addition to the presence of DQ2. The TNFA -308 polymorphism and the polymorphism at the first intron of the LTA gene were typed in CD patients and healthy controls and the results were correlated with the presence of DQ2. Significant differences were found in genotype and allele frequencies for the TNFA and LTA genes between CD patients and controls, with an increase in the presence of the TNFA*2 and LTA*1 alleles in CD patients. These differences increase when DQ2-positive CD patients and DQ2-positive controls are compared. In DQ2-positive individuals, allele 2 (A) in position -308 of the promoter of TNFA and allele 1 (G) of the NcoI RFLP in the first intron of LTA are additional risk markers for CD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439617     DOI: 10.1007/s00251-002-0498-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  7 in total

1.  Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population.

Authors:  Rajeev Mahajan; Emad M El-Omar; Jolanta Lissowska; Paolo Grillo; Charles S Rabkin; Andrea Baccarelli; Meredith Yeager; Leslie H Sobin; Witold Zatonski; Stephen J Channock; Wong-Ho Chow; Lifang Hou
Journal:  Jpn J Clin Oncol       Date:  2008-08-07       Impact factor: 3.019

2.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

3.  Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles.

Authors:  Andrew S Louka; Benedicte A Lie; Bente Talseth; Henry Ascher; Johan Ek; Audur H Gudjónsdóttir; Ludvig M Sollid
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

4.  TNF-α -308 G > A (rs1800629) Polymorphism is Associated with Celiac Disease: A Meta-analysis of 11 Case-Control Studies.

Authors:  Saif Khan; Raju K Mandal; Arshad Jawed; Sajad A Dar; Mohd Wahid; Aditya K Panda; Mohammed Y Areeshi; Md Ekhlaque Ahmed Khan; Shafiul Haque
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

5.  Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project.

Authors:  Salvador Pastor-Idoate; Irene Rodríguez-Hernández; Jimena Rojas; Lucia Gonzalez-Buendia; Santiago Delgado-Tirado; Jose Carlos López; Rogelio González-Sarmiento; Jose C Pastor
Journal:  Clin Ophthalmol       Date:  2017-05-22

6.  TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children.

Authors:  Elisa Rossi; Daniela Basso; Carlo-Federico Zambon; Filippo Navaglia; Eliana Greco; Michela Pelloso; Serena Artuso; Andrea Padoan; Matilde Pescarin; Ada Aita; Dania Bozzato; Stefania Moz; Mara Cananzi; Graziella Guariso; Mario Plebani
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

7.  Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patients.

Authors:  Sara Vallejo-Diez; David Bernardo; María de Lourdes Moreno; Alba Muñoz-Suano; Luis Fernández-Salazar; Carmen Calvo; Carolina Sousa; José A Garrote; Angel Cebolla; Eduardo Arranz
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.